Coralville, IA – According to filings with the U.S. Securities and Exchange Commission, VIDA is raising $14,775,969.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Susan Wood played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About VIDA

VIDA is transforming lung care through intelligence, using imaging-based AI to uniquely profile and manage the patient with or at-risk of respiratory diseases.  VIDA’s LungPrint solution aims to provide greater precision and personalization across a range of lung diseases including lung cancer, obstructive airway diseases like emphysema and asthma, and interstitial lung disease.  VIDA’s software and services are available for clinical use in the USA, EU, Canada and Australia.

To learn more about VIDA, visit http://vidadiagnostics.com/

Contact:
Susan Wood, President and Chief Executive Officer
855-900-8432
susanwood@vidadiagnostics.com
https://www.linkedin.com/in/susan-wood-b175242/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved